Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
暂无分享，去创建一个
P. Pais | Á. Avezum | A. Parkhomenko | C. Held | R. Diaz | E. Lonn | P. Armstrong | C. Cannon | H. White | W. Weaver | C. Granger | E. Hagström | R. D. de Winter | D. Ardissino | M. Flather | A. Budaj | J. López-Sendón | W. Koenig | E. Mohler | A. Siegbahn | L. Wallentin | P. Sinnaeve | J. Hochman | R. Harrington | R. Sy | H. Tse | P. Aylward | P. Steg | D. Pella | Hyo‐Soo Kim | N. Danchin | R. Stewart | J. Nicolau | M. Viigimaa | M. Ruda | A. Manolis | T. Teramoto | T. Pedersen | P. Sritara | A. Linhart | S. Husted | R. Weiss | L. Grinfeld | D. Vinereanu | R. Corbalán | S. Siddique | Ming-Fong Chen | H. Swart | M. Elisaf | Hong Chen | J. López-Sendón | S. Krug‐Gourley | R. Davies | S. Denchev | Jun-ren Zhu | A. Goudev | A. Parkhomenko | O. Östlund | E. Tarka | A. Dalby | Alfonso Bryce | M. A. Ramos-Corrales | M. Sereg | Stability Investigators | Peter Sinnaeve | Aleš Linhart | E. Lonn | W. D. Weaver | A. Goudev | D. Pella | M. Flather | Jose C. Nicolau | A. Manolis | R. Corbalán | Prem Pais | Diego Ardissino | Margus Viigimaa | Moses Elisaf | Tamio Teramoto | Steen Husted | Álvaro Avezum | Hung-Fat Tse | Andrzej Budaj | Alfonso Bryce | Hong Chen | Ming‐Fong Chen | N. Danchin | Rafael Diaz | Hyo‐Soo Kim | Saulat Siddique | Junren Zhu